These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31432980)

  • 21. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood pressure cutoffs for white-coat and masked effects in a large population undergoing home blood pressure monitoring.
    Feitosa ADM; Mota-Gomes MA; Barroso WS; Miranda RD; Barbosa ECD; Pedrosa RP; Oliveira PC; Feitosa CLDM; Brandão AA; Lima-Filho JL; Sposito AC; Coca A; Nadruz W
    Hypertens Res; 2019 Nov; 42(11):1816-1823. PubMed ID: 31263210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discordance between ambulatory versus clinic blood pressure according to global cardiovascular risk group.
    Shin J; Park SH; Kim JH; Ihm SH; Kim KI; Kim WS; Pyun WB; Kim YM; Choi SI; Kim SK
    Korean J Intern Med; 2015 Sep; 30(5):610-9. PubMed ID: 26354055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart rate turbulence in masked hypertension and white-coat hypertension.
    Song CL; Zhang X; Liu YK; Yue WW; Wu H
    Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1457-60. PubMed ID: 25967722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical correlates of ambulatory BP monitoring among patients with CKD.
    Iimuro S; Imai E; Watanabe T; Nitta K; Akizawa T; Matsuo S; Makino H; Ohashi Y; Hishida A;
    Clin J Am Soc Nephrol; 2013 May; 8(5):721-30. PubMed ID: 23411432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. White coat hypertension in early pregnancy in women with pre-existing diabetes: prevalence and pregnancy outcomes.
    Vestgaard M; Ásbjörnsdóttir B; Ringholm L; Andersen LLT; Jensen DM; Damm P; Mathiesen ER
    Diabetologia; 2019 Dec; 62(12):2188-2199. PubMed ID: 31628489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension: Analysis From the Dallas Heart Study.
    Tientcheu D; Ayers C; Das SR; McGuire DK; de Lemos JA; Khera A; Kaplan N; Victor R; Vongpatanasin W
    J Am Coll Cardiol; 2015 Nov; 66(20):2159-2169. PubMed ID: 26564592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subclinical arterial and cardiac damage in white-coat and masked hypertension.
    Wojciechowska W; Stolarz-Skrzypek K; Olszanecka A; Klima Ł; Gąsowski J; Grodzicki T; Kawecka-Jaszcz K; Czarnecka D
    Blood Press; 2016 Aug; 25(4):249-56. PubMed ID: 26953075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Office blood pressure values and the necessity of out-of-office measurements in high-risk pregnancies.
    Salazar MR; Espeche WG; Balbín E; Leiva Sisnieguez CE; Leiva Sisnieguez BC; Stavile RN; March C; Olano RD; Soria A; Yoma O; Prudente M; Torres S; Grassi F; Santillan C; Carrera Ramos P; Carbajal HA
    J Hypertens; 2019 Sep; 37(9):1838-1844. PubMed ID: 31157745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. White-coat and masked hypertension diagnoses in chronic kidney disease patients.
    Pereira H; Bonilha A; Barretti P; Silva R; Burgugi V; Dos Santos V; Cuadrado L
    J Clin Hypertens (Greenwich); 2020 Jul; 22(7):1202-1207. PubMed ID: 32608106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of new-onset metabolic syndrome associated with white-coat and masked hypertension: data from a general population.
    Cuspidi C; Facchetti R; Bombelli M; Sala C; Tadic M; Grassi G; Mancia G
    J Hypertens; 2018 Sep; 36(9):1833-1839. PubMed ID: 29965885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Correlates of Ambulatory Blood Pressure Phenotypes at a Tertiary Care Hospital in Turkey.
    Erdogmus S; Kutlay S; Celebi ZK; Aydın T; Ors Sendogan D; Kumru G; Keven K; Nergizoglu G; Erturk S; Sengul S
    Kidney Blood Press Res; 2018; 43(3):690-700. PubMed ID: 29763911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of miscuffing during home blood pressure measurement on the prevalence of masked hypertension.
    Mourad JJ; Lopez-Sublet M; Aoun-Bahous S; Villeneuve F; Jaboureck O; Dourmap-Collas C; Denolle T; Fourcade J; Baguet JP
    Am J Hypertens; 2013 Oct; 26(10):1205-9. PubMed ID: 23727841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of apelin and relaxin plasma levels in masked hypertension and white coat hypertension.
    Sanidas E; Tsakalis K; Papadopoulos DP; Zerva K; Velliou M; Perrea D; Mantzourani M; Iliopoulos D; Barbetseas J
    J Clin Hypertens (Greenwich); 2019 Jan; 21(1):48-52. PubMed ID: 30525273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Home blood pressure control status in 2017-2018 for hypertension specialist centers in Asia: Results of the Asia BP@Home study.
    Kario K; Tomitani N; Buranakitjaroen P; Chia YC; Park S; Chen CH; Divinagracia R; Shin J; Siddique S; Sison J; Ann Soenarta A; Sogunuru GP; Tay JC; Turana Y; Zhang Y; Nailes J; Wanthong S; Hoshide S; Matsushita N; Kanegae H; Wang JG;
    J Clin Hypertens (Greenwich); 2018 Dec; 20(12):1686-1695. PubMed ID: 30444315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toward a definition of masked hypertension and white-coat hypertension among hemodialysis patients.
    Agarwal R; Sinha AD; Light RP
    Clin J Am Soc Nephrol; 2011 Aug; 6(8):2003-8. PubMed ID: 21737856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Target organ damage in "white coat hypertension" and "masked hypertension".
    Kotsis V; Stabouli S; Toumanidis S; Papamichael C; Lekakis J; Germanidis G; Hatzitolios A; Rizos Z; Sion M; Zakopoulos N
    Am J Hypertens; 2008 Apr; 21(4):393-9. PubMed ID: 18292757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proportion of US Adults Recommended Out-of-Clinic Blood Pressure Monitoring According to the 2017 Hypertension Clinical Practice Guidelines.
    Booth JN; Hubbard D; Sakhuja S; Yano Y; Whelton PK; Wright JT; Shimbo D; Muntner P
    Hypertension; 2019 Aug; 74(2):399-406. PubMed ID: 31230550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of white-coat and masked hypertension in national and international registries.
    Gorostidi M; Vinyoles E; Banegas JR; de la Sierra A
    Hypertens Res; 2015 Jan; 38(1):1-7. PubMed ID: 25319601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of masked and white-coat hypertension in the general population: the Finn-Home Study.
    Hänninen MR; Niiranen TJ; Puukka PJ; Johansson J; Jula AM
    J Hypertens; 2012 Apr; 30(4):705-12. PubMed ID: 22278146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.